Author

P. Kshetrapal

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Assay:proteomics· 3 Organism:human· 2 Organism:mouse· 2 Research Focus:cell-cell communication· 1 Approach:statistical model· 1

Frequent Co-Authors

R. Thiruvengadam· 3 shared S. Singh· 3 shared D. K. Rathore· 2 shared D. Sok· 2 shared G. Batra· 2 shared G. R. Medigeshi· 2 shared J. Bhattacharya· 2 shared J. Singh· 2 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

R. Thiruvengadam

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

SARS-CoV-2 spike antibodies cross-react with dengue virus and enhance infection in vitro and in vivo

K. Jakhar, S. Sonar, G. Singh, T. R. Asuru, G. Joshi, N. Beniwal, T. Sarkar, M. Tiwari, J. Kaur, D. K. Rathore, B. Lal, S. Kumar, P. Srivastav, S. Kumar, V. Phagna, , S. Mani

The paper shows that SARS-CoV-2 spike antibodies can enhance DENV2 infection in vitro and in vivo, suggesting potential for increased dengue severity in COVID-19 survivors.

bioRxiv · Oct 9, 2023Immunology

Ancestral SARS-CoV-2 driven antibody repertoire diversity in an unvaccinated individual correlates with expanded neutralization breadth

S. Deshpande, M. Y. Ansari, J. Sutar, P. Das, N. Hingankar, S. Mukherjee, P. Jayal, S. Singh, A. Anantharaj, J. Singh, S. Chattopadhyay, S. Raghavan, M. Gosain, S. Chauhan, S. Shrivas, , J. Bhattacharya

The paper examines antibody diversity in an unvaccinated SARS-CoV-2 infected individual, finding that post-vaccination neutralization breadth against Omicron variants is comparable to vaccinated individuals and breakthrough infections.

bioRxiv · Oct 19, 2022Immunology

A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 delta variant

N. Hingankar, S. Deshpande, P. Das, Z. A. Rizvi, A. Burns, S. Barman, F. Zhao, M. Y. Ansari, S. Mukherjee, J. L. Torres, S. Chattopadhyay, F. Mehdi, J. Sutar, D. K. Rathore, K. Pargai, , J. Bhattacharya

This paper identifies two potent monoclonal antibodies from an Indian donor that neutralize SARS-CoV-2 variants including Delta, showing protection in a mouse model.

bioRxiv · Dec 25, 2021Immunology